Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective

被引：3

作者：

Friesen, Chance S. ^{[1
]}

Chan, Sherwin S. ^{[2
,3
]}

Wagner, Jonathan B. ^{[2
,3
]}

Hosey-Cojocari, Chelsea ^{[2
]}

Csanaky, Ivan L. ^{[2
,3
,4
]}

Shakhnovich, Valentina ^{[2
,3
,4
,5
]}

机构：

[1] Univ Kansas, Sch Med, Kansas City, MO USA

[2] Childrens Mercy Kansas City, 2401 Gillham Rd, Kansas City, MO 64108 USA

[3] Univ Missouri, Sch Med, Kansas City, MO 64108 USA

[4] Univ Kansas, Med Ctr, Kansas City, MO USA

[5] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA

来源：

CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 03期

关键词：

D O I：

10.1111/cts.12952

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects up to 70% of children with obesity and has become the number one etiology for liver transplant in the United States. Early, effective intervention is critical to prevent disease progression into adulthood. Yet, it is seldom achieved through lifestyle modification alone. Thus, children must be included in NAFLD pharmacology trials, which, to date, continue to focus primarily on adult populations. This commentary serves as a call to action.

引用

页码：781 / 783

页数：3

共 50 条

[21] The safety of pharmacologic options for the treatment of persons with hemophilia
Franchini, Massimo
Mannucci, Pier Mannuccio
EXPERT OPINION ON DRUG SAFETY, 2016, 15 (10) : 1391 - 1400
[22] A review of the pharmacologic options for the treatment of alcohol dependence
Angelini, Michael
Brahmbhatt, Yogini
FORMULARY, 2007, 42 (01) : 14 - +
[23] New treatment options for erectile dysfunction.: Pharmacologic and nonpharmacologic options
Sperling, H
Lümmen, G
Schneider, T
Rübben, H
HERZ, 2003, 28 (04) : 314 - 324
[24] The safety of pharmacologic treatment for pediatric obesity
Chao, Ariana M.
Wadden, Thomas A.
Berkowitz, Robert I.
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (04) : 379 - 385
[25] Pharmacologic Treatment of Pediatric Migraine Prevention
不详
PEDIATRICS, 2019, 144 (05)
[26] Pharmacologic Treatment of Pediatric Anxiety Disorders
Hussain F.S.
Dobson E.T.
Strawn J.R.
Current Treatment Options in Psychiatry, 2016, 3 (2) : 151 - 160
[27] Pharmacologic Treatment of Pediatric Bipolar Disorder
Nandagopal, Jayasree J.
DelBello, Melissa P.
Kowatch, Robert
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2009, 18 (02) : 455 - +
[28] Alzheimer's dementia: non-pharmacologic and pharmacologic treatment options in 2015
Kressig, Reto W.
THERAPEUTISCHE UMSCHAU, 2015, 72 (04) : 233 - 238
[29] Pharmacologic treatment of chronic pediatric hypertension
Robinson R.F.
Nahata M.C.
Batisky D.L.
Mahan J.D.
Pediatric Drugs, 2005, 7 (1) : 27 - 40
[30] Current Options and Future Directions for NAFLD and NASH Treatment
Zhang, Chunye
Yang, Ming
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)

← 1 2 3 4 5 →